Basics
Description
- Cushing disease: Pituitary adenoma producing excess adrenocorticotropic hormone (ACTH)
- Cushing syndrome: Excessive glucocorticoid effects
Risk Factors
Genetics
- Multiple endocrine neoplasia type I
- Carney complex (pigmented lentigines, atrial myxoma, germ-cell tumors with Cushing disease)
Etiology
- Most commonly exogenous administration of glucocorticoids either therapeutically or surreptitiously
- Pituitary adenoma secreting ACTH
- Adrenal production of cortisol from adenoma, carcinoma, or micronodular disease
- Tumor-producing ectopic ACTH:
- Small cell lung carcinoma:
- Uterine cervical carcinoma
- Islet cell tumor of pancreas:
- Multiple endocrine neoplasia (MEN) I-type syndrome
- Medullary thyroid cancer
- Pheochromocytoma
- Ganglioneuroma
- Melanoma prostate carcinoma
- Carcinoid tumor:
- Lung
- Pancreas
- GI tract
- Thymus
- Ovary
Diagnosis
Signs and Symptoms
- The most important aspect of Cushing syndrome in the ED is recognizing the potential for addisonian (adrenal) crisis during periods of stress.
- Although nonemergent, the early recognition of Cushing syndrome may prevent morbidity and mortality.
Suspect if increasing in obesity while failing to maintain height on the growth chart
Cushing syndrome rarely complicates pregnancy, but has been associated with severe pre-eclampsia and HELLP syndrome (hemolysis, elevated liver function, and low platelets)
History
- Cushing disease previously diagnosed
- Prior use of corticosteroids
- Characteristic appearance should lead to questions concerning change in weight, facial appearance, hirsutism, or psychiatric symptoms
Physical Exam
- Diagnosis suggested by:
- Abnormal fat deposition with moon facies
- Buffalo hump
- Central obesity with thin extremities
- Supraclavicular fat deposition:
- Above findings raise suspicion in a stressed patient of potentially developing addisonian (adrenal) crisis
- Cardiovascular:
- Uncontrolled hypertension
- Neurologic:
- Atherosclerotic or embolic stroke
- Pseudotumor cerebri (primarily with exogenous glucocorticoid administration):
- Spinal lipomatosis with cord or nerve-root compression
- Gastroenterologic:
- Peptic ulcers
- GI hemorrhage
- Pancreatitis (primarily with exogenous glucocorticoid administration)
- Fatty liver
- Psychiatric:
- Toxic psychosis
- Mood disorders (40%)
- Depression
- Memory impairment
- Euphoria
- Musculoskeletal:
- Myopathy (proximal weakness)
- Pathologic fractures
- Osteoporosis
- Aseptic necrosis humeral or femoral heads (primarily with exogenous glucocorticoid administration)
- Endocrine:
- Glucose intolerance
- Hyperlipidemia
- Amenorrhea, female with male pattern balding, or hirsutism
- Hematologic:
- Increased neutrophils
- Decreased lymphocytes and eosinophils
- Opportunistic infections
- Ophthalmologic:
- Cataracts (primarily with exogenous glucocorticoid administration)
- Glaucoma (primarily with exogenous glucocorticoid administration)
- Dermatologic:
- Purple striae >1 cm in diameter
- Hyperpigmentation: Especially of buccal mucosa (from excess ACTH production)
- Facial plethora
- Thin skin
- Impaired wound healing
- Ecchymoses
- Acne
- Hyperhidrosis
Essential Workup
- Cannot confirm diagnosis in ED
- Anticipate impending addisonian (adrenal) crisis:
- Most frequent and common problem with Cushing syndrome is its recognition with concurrent illness to prevent acute Addisonian crisis
- Search for life-threatening conditions:
- MI
- Stroke
- Sepsis
- Pathologic fracture
- Uncontrolled DM
- Psychiatric emergency necessitating admission
Diagnosis Tests & Interpretation
Lab
- Electrolytes, BUN, creatinine, glucose:
- Hypokalemia
- 10% with metabolic alkalosis
- Diminished glucose tolerance (75%)
- 20% overt DM
- Urinalysis:
- CBC:
- Increased WBCs
- Decreased eosinophils
Imaging
- ECG for myocardial ischemia
- CXR for tumor-causing ectopic ACTH
- Plain films if suspect possible pathologic fractures:
Diagnostic Procedures/Surgery
Nonemergent testing:
- MRI for pituitary tumor
- CT for adrenal carcinoma, adenoma, or hyperplasia
- Dexamethasone-suppression test (follow-up study with primary physician):
- If suspicion of endogenous Cushing syndrome exists
- Low-dose (screening test): 1 mg at 11:00 pm with an 8 am cortisol level drawn:
- False-positive results from alcohol, estrogens, spironolactone, phenytoin, barbiturates, and rifampin:
- High-dose dexamethasone-suppression test needed to confirm the diagnosis:
- 2 mg QID of dexamethasone with cortisol level 6 hr later
- Compare day 2 urine-free cortisol and 17-hydroxyketosteroids with baseline levels.
Differential Diagnosis
- Alcohol-induced pseudo-Cushing syndrome
- Obesity
- Psychiatric states:
- Depression
- Obsessive-compulsive disorder
- Panic disorder
- Physiologic states:
- Chronic stress
- 3rd-trimester pregnancy
- Chronic strenuous exercise
Treatment
Pre-Hospital
- Acute addisonian (adrenal) crisis under stress may develop with iatrogenic Cushing syndrome
- Patients may have extremely labile behavior with violent behavior
- Leading causes of death in untreated Cushing syndrome are:
Initial Stabilization/Therapy
- Anticipate addisonian (adrenal) crisis.
- Initiate treatment for associated complications:
- MI
- Stroke
- Psychiatric stabilization
Ed Treatment/Procedures
- IV rehydration
- Glucose-lowering agents for hyperglycemia
- Appropriate cultures and antibiotics for suspected infection
- Antihypertensive agents for uncontrolled BP
- Administer steroids (hydrocortisone) with iatrogenic Cushing if patient under stress to prevent addisonian crisis.
- Medications to lower cortisol levels (bromocriptine, ketoconazole, aminoglutethimide, metyrapone):
- Used rarely with severe symptoms in patients awaiting surgery
- Institute under the direction of an endocrinologist.
- Definitive therapy:
- Iatrogenic:
- Taper steroids as rapidly as possible
- Calcium, vitamin D, and estrogen supplementation if possible
- Pituitary Cushing:
- Transsphenoidal surgery
- Radiation for surgical failures and a few select patients
- Adrenal adenoma/carcinoma:
- Adrenal resection with medical therapy for metastatic lesions not resectable
- Ectopic ACTH:
- Tumor resection (if possible) with medical therapy for metastatic lesions not resectable
Medication
First Line
ONLY if in adrenal crisis: Hydrocortisone: 100 mg (peds: 1-2 mg/kg) IV q6h
Second Line
- In consultation with an endocrinologist
- SYMPTOMATIC TREATMENT ONLY as adjunctive therapy in patients awaiting surgery or refractory to other treatment
- Steroidogenic inhibitors:
- Ketoconazole 200 mg PO BID
- Methyrapone 0.5-1 g/d PO in 4 div. doses
- Aminoglutethimide 250 mg PO q6h
- Mifepristone 300 mg PO daily
- Adrenolytics:
- ACTH release inhibitors:
- Cyproheptadine 4 mg PO BID
- Bromocriptine 2.5-30 mg/d
- Other:
- Pasireotide 0.6 mg SQ initial
- Spironolactone for symptomatic relief of HTN or hypokalemia
Follow-Up
Disposition
Admission Criteria
- Complications that require admission such as:
- MI
- Stroke
- Sepsis
- Pathologic fracture
- Uncontrolled DM
- Psychiatric emergency
- Impending addisonian (adrenal) crisis
Discharge Criteria
Well-appearing, stable patient without admission criteria
Issues for Referral
- Any patient suspected of Cushing syndrome for further evaluation
- Conditions secondary to Cushing requiring treatment
Followup Recommendations
Follow-up testing to confirm diagnosis
Pearls and Pitfalls
- Keep a high index of suspicion in the physiologically stressed patient by history or from body habitus and for the need to prevent against addisonian crisis
- Suspect Cushing disease when there are supraclavicular fat pads
Additional Reading
- Andreoli T, Carpenter C. Cecil Essentials of Medicine. 8th ed. Philadelphia, PA: Saunders-Elsevier; 2010.
- Gilbert R, Lim EM. The diagnosis of Cushing syndrome: An endocrine society clinical practice guideline. Clin Biochem Rev. 2008;29:103-106.
- Goldman L, Bennett JC, eds. Cecils Textbook of Medicine. 23rd ed. Philadelphia, PA: Saunders-Elsevier; 2008.
- Guaraldi F, Salvatori R. Cushing syndrome: Maybe not so uncommon of an endocrine disease. J Am Board Fam Med. 2012;25(2):199-208.
Codes
ICD9
255.0 Cushings syndrome
ICD10
- E24.0 Pituitary-dependent Cushings disease
- E24.2 Drug-induced Cushing's syndrome
- E24.9 Cushing's syndrome, unspecified
- E24.8 Other Cushing's syndrome
- E24.3 Ectopic ACTH syndrome
SNOMED
- 47270006 Hypercortisolism (disorder)
- 190502001 Pituitary-dependent Cushings disease (disorder)
- 237734007 ACTH-dependent Cushing's syndrome
- 41299009 Iatrogenic Cushing's disease
- 626004 Hypercortisolism due to nonpituitary tumor (disorder)